Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Academia and Government
February 15, 2017
Academia and Government
February 13, 2017
Academia and Government
January 30, 2017
Life Sciences and Healthcare
January 29, 2017
Academia and Government
January 24, 2017
Life Sciences and Healthcare
January 24, 2017